Fibroblast Growth Factor-2 Can Mediate Cell Attachment by Linking Receptors and Heparan Sulfate Proteoglycans on Neighboring Cells (*)

The myeloid 32D cell line, which grows in suspension and does not express FGF receptors or heparan sulfate proteoglycans, was transfected with the cDNA encoding FGF receptor-1 (32D-flg cells). When co-cultured with glutaraldehyde-fixed Chinese hamster ovary (CHO) cells, the 32D-flg cells remained in suspension in the absence of FGF-2 but attached to the CHO monolayer in the presence of 10 ng/ml FGF-2. In contrast, 32D cells transfected with the vector alone did not attach to the CHO monolayer in the presence of FGF-2. FGF-2-dependent attachment of 32D-flg cells was prevented by inclusion of 10 μg/ml heparin in the incubation medium and was diminished when CHO mutants in glycosaminoglycan synthesis or wild-type CHO cells treated with heparinase were used, indicating that the attachment occurred through FGF-2 interactions with heparan sulfates on the CHO cells. Attachment of 32D-flg cells to wild-type CHO cells was half-maximal at 0.4 ng/ml FGF-2 and was also observed with FGF-1 but not FGF-4. 32D-flg cells also attached to living CHO cells in a FGF-2-dependent manner, but attachment was transient at 37°C. Induction of new proteins was not required for FGF-2-dependent attachment, since attachment occurred when the co-cultures were incubated at 4°C and when the 32D-flg cells were preincubated with cycloheximide. FGF-2-dependent attachment of 32D-flg cells was also observed with Balb/C 3T3, NIH 3T3, and bovine capillary endothelial cells. We conclude that attachment is due to FGF-2 binding simultaneously to receptors on the 32D-flg cells and heparan sulfates on the CHO monolayers; thus, the FGF-2 acts as a bridge between receptorexpressing cells and heparan sulfate-bearing cells. In addition, induction of DNA synthesis in 32D-flg cells in response to FGF-2 was potentiated by the CHO-associated heparan sulfates to the same extent as by soluble heparin, indicating that this interaction has functional significance.

[1]  D. Moscatelli,et al.  The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.

[2]  J. Gabrilove,et al.  Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. , 1994, Blood.

[3]  M. Rusnati,et al.  Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form , 1989, Journal of cellular physiology.

[4]  J. Massagué,et al.  Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Moscatelli,et al.  A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Gabrilove,et al.  Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. , 1991, Blood.

[7]  E. Wilson,et al.  Basic fibroblast growth factor antagonizes transforming growth factor beta-mediated erythroid differentiation in K562 cells. , 1994, Blood.

[8]  D. Moscatelli,et al.  Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. , 1992, The Journal of biological chemistry.

[9]  O. Blaschuk,et al.  Fibroblast growth factor receptors contain a conserved HAV region common to cadherins and influenza strain A hemagglutinins: a role in protein-protein interactions? , 1992, Developmental biology.

[10]  S. O. Kolset,et al.  Proteoglycans in haemopoietic cells. , 1990, Biochimica et biophysica acta.

[11]  L. Parise,et al.  Regulation of vascular integrins. , 1993, Blood.

[12]  S. Bentley.  BONE MARROW CONNECTIVE TISSUE AND THE HAEMOPOIETIC MICROENVIRONMENT , 1982, British journal of haematology.

[13]  M. Rusnati,et al.  Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin‐like bFGF receptors , 1993, Journal of cellular physiology.

[14]  J. Esko.  Genetic analysis of proteoglycan structure, function and metabolism. , 1991, Current opinion in cell biology.

[15]  Y. Courtois,et al.  Specific binding of basic fibroblast growth factor to basement membrane‐like structures and to purified heparan sulfate proteoglycan of the EHS tumor , 1988, Journal of cellular physiology.

[16]  T. Sugimura,et al.  Expression of the heparin-binding growth factor receptor genes in human megakaryocytic leukemia cells. , 1992, Biochemical and biophysical research communications.

[17]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[18]  N. Ling,et al.  Multiple influences of a heparin-binding growth factor on neuronal development , 1987, The Journal of cell biology.

[19]  M. Klagsbrun,et al.  A dual receptor system is required for basic fibroblast growth factor activity , 1991, Cell.

[20]  R. Hoffman,et al.  Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. , 1993, Blood.

[21]  M. Jaye,et al.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.

[22]  E. Edelman,et al.  Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. , 1992, Biochemistry.

[23]  B. Olwin,et al.  Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate , 1992, The Journal of cell biology.

[24]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[25]  J. Partanen,et al.  Expression of fibroblast growth factor receptors in human leukemia cells. , 1992, Cancer research.

[26]  G. Wong,et al.  Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells , 1993 .

[27]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[28]  C. Peschle,et al.  "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. , 1990, Science.

[29]  D. Barritault,et al.  Internalization of basic fibroblast growth factor by Chinese hamster lung fibroblast cells: involvement of several pathways. , 1991, Experimental cell research.

[30]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[31]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[32]  P. Barr,et al.  Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. , 1991, Growth factors.

[33]  K. Ozawa,et al.  Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. , 1993, Blood.

[34]  M. Jaye,et al.  Cloning and expression of two distinct high‐affinity receptors cross‐reacting with acidic and basic fibroblast growth factors. , 1990, The EMBO journal.

[35]  P. Barr,et al.  Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[37]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.

[39]  J. Xu,et al.  Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants , 1993, Molecular and cellular biology.

[40]  H. Hanafusa,et al.  Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Lear,et al.  Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.

[42]  D. Rifkin,et al.  Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor , 1990, The Journal of cell biology.

[43]  D. Moscatelli,et al.  Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. , 1992, The Journal of biological chemistry.

[44]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[45]  A. Isacchi,et al.  Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli. , 1992, European journal of biochemistry.

[46]  S. Nishikawa,et al.  Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. , 1994, Experimental hematology.

[47]  M. Jaye,et al.  Ligand‐induced transphosphorylation between different FGF receptors. , 1991, The EMBO journal.

[48]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[49]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[51]  M. Hayman,et al.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Fuhrmann,et al.  Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. , 1992, Blood.

[53]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[54]  D. Rifkin,et al.  Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis , 1989, Journal of cellular physiology.